Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zocaglusagene nuzaparvovec by Astellas Gene Therapies for Pompe Disease: Likelihood of Approval
Zocaglusagene nuzaparvovec is under clinical development by Astellas Gene Therapies and currently in Phase II for Pompe Disease. According to...